Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Social Determinants of Health 2Exercise 2sofosbuvir-velpatasvir drug combination 1ribociclib 1palbociclib 1ibrutinib 1amlodipine, atorvastatin drug combination 1acalabrutinib 1abemaciclib 1Standard of Care 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Methods 1Interviews as Topic 1Hematologic Tests 1Fish Oils 1Fatty Acids, Omega-3 1Electrocardiography 1Educational Status 1Echocardiography 1Early Intervention, Educational 1Diet 1Cholecalciferol 1Chemoradiotherapy 1Atorvastatin 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Cardiovascular Diseases × Fatty Acids, Omega-3 × Clear all
NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡